Fraunhofer USA competitors

Nina Joshi is a President/CEO at Ues Inc. She has worked as Trustee at Wright State University.

A sense of wonder, attempt to understand life (biology), and chain of unanswered childhood questions began to converge when Charles made his first observation of leukemia cells under the microscope as an undergraduate at UC Davis. His love for cell biology grew through isolation, differentiation, and genetic modification of various stem cell populations that he investigated in graduate studies at UC Davis. Charles sought ways to provide stem cells with a microenvironment that could regulate the intricate balance between self-renewal and lineage commitment. This effort led to the development of the hyper-crosslinked carbohydrate polymer (HCCP), which became the basic building block of a tissue engineering programs aimed to develop a personalized, regenerative therapy. After the initial development and proof-of-concept studies at UC Davis, he founded Molecular Matrix, Inc in 2011 to bring the HCCP technology to patients with bone-related diseases through regulatory studies. Charles works closely with researchers, surgeons, business developers, financial and regulatory professionals at Molecular Matrix, Inc. to create and maintain a corporate culture that fosters integrity, innovation, and passion for improving the quality of life for people in need.

Allan Jones is President and Chief Executive Officer of the Allen Institute, an independent, nonprofit research organization dedicated to answering some of the biggest questions in bioscience and advancing our knowledge to improve human health. Researchers at the Allen Institute study the unknowns of biology with major efforts in the brain, the cell and the immune system. Jones was one of the Allen Institute’s four founding employees when the nonprofit launched in 2003, originally as the Allen Institute for Brain Science, and took the helm within the first few years to manage its growth and impact, eventually leading the launch of the Institute’s other three scientific divisions. Along with the Allen Institute’s founder, the late philanthropist Paul G. Allen, Jones pioneered a unique approach to neuroscience, and later to other areas of bioscience, through the Institute’s core principles of big science, team science and open science. Jones has continued to champion the need for open data sharing and the broader importance of open science. Jones’ publications have garnered approximately 1,000 highly influential citations on Semantic Scholar. His 2011 TED Talk: “A map of the brain” has been viewed nearly 1.25 million times. He has advised and helped organize many current U.S. and global neuroscience initiatives, including the National Institutes of Health’s BRAIN Initiative, the Human Brain Project and the International Brain Initiative. Jones currently serves on several advisory boards and the Fred Hutchinson Cancer Research Center Board of Trustees, and he is the former Chair of the World Economic Forum’s Global Agenda Council on Neuroscience and Behavior. Originally from Wichita, Kansas, Jones received a B.S. in biology from Duke University and a Ph.D. in genetics and developmental biology from Washington University School of Medicine. After a brief period as a post doc at the University of Pennsylvania, Jones joined Avitech Diagnostics, a small start-up company in Philadelphia. He moved to Seattle to work for Rosetta Inpharmatics, which was later acquired by Merck and Co.